Literature DB >> 16251332

Efficacy of penicillin versus cefdinir in eradication of group A streptococci and tonsillar flora.

Itzhak Brook1, Perry A Foote.   

Abstract

Core tonsillar cultures were obtained from 40 children with recurrent tonsillitis treated with either penicillin or cefdinir. Group A beta-hemolytic streptococci were isolated from 11 penicillin- and 3 cefdinir-treated (P < 0.001) patients. beta-Lactamase producers were recovered from 17 penicillin- and 3 cefdinir-treated (P < 0.01) patients. Inhibiting alpha-hemolytic streptococci were isolated less often from penicillin-treated patients than from cefdinir-treated patients.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16251332      PMCID： PMC1280135          DOI： 10.1128/AAC.49.11.4787-4788.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  15 in total

1.  Evaluation of beta-lactamase activity and microbial interference in treatment failures of acute streptococcal tonsillitis.

Authors:  K Roos; E Grahn; S E Holm
Journal:  Scand J Infect Dis       Date:  1986

2.  Interference of alpha-hemolytic streptococci isolated from tonsillar surface on beta-hemolytic streptococci (Streptococcus pyogenes)--a methodological study.

Authors:  E Grahn; S E Holm; C Ekedahl; K Roos
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1983-07

3.  Penicillin and clindamycin therapy in recurrent tonsillitis. Effect of microbial flora.

Authors:  P A Foote; I Brook
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1989-07

4.  Comparison of cefdinir and penicillin V in the treatment of pediatric streptococcal tonsillopharyngitis.

Authors:  M E Pichichero; W M Gooch
Journal:  Pediatr Infect Dis J       Date:  2000-12       Impact factor: 2.129

5.  Interfering alpha-streptococci as a protection against recurrent streptococcal tonsillitis in children.

Authors:  K Roos; E Grahn; S E Holm; H Johansson; L Lind
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1993-01       Impact factor: 1.675

6.  Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in children.

Authors:  Janet R Casey; Michael E Pichichero
Journal:  Pediatrics       Date:  2004-04       Impact factor: 7.124

7.  BMY-28100, a new oral cephalosporin: antimicrobial activity against nearly 7,000 recent clinical isolates, comparative potency with other oral agents, and activity against beta-lactamase producing isolates.

Authors:  R N Jones; A L Barry
Journal:  Diagn Microbiol Infect Dis       Date:  1988-01       Impact factor: 2.803

8.  Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis.

Authors:  A S Gastanaduy; E L Kaplan; B B Huwe; C McKay; L W Wannamaker
Journal:  Lancet       Date:  1980-09-06       Impact factor: 79.321

Review 9.  The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection.

Authors:  I Brook
Journal:  Rev Infect Dis       Date:  1984 Sep-Oct

10.  Quantitative measurement of beta lactamase in tonsils of children with recurrent tonsillitis.

Authors:  I Brook; P Yocum
Journal:  Acta Otolaryngol       Date:  1984 Nov-Dec       Impact factor: 1.494
View more
  4 in total

1.  Penicillin failure in the treatment of streptococcal pharyngo-tonsillitis.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

Review 2.  Treatment Challenges of Group A Beta-hemolytic Streptococcal Pharyngo-Tonsillitis.

Authors:  Itzhak Brook
Journal:  Int Arch Otorhinolaryngol       Date:  2016-06-03

3.  Treatment of Pediatric Acute-Onset Neuropsychiatric Disorder in a Large Survey Population.

Authors:  Denise Calaprice; Janice Tona; Tanya K Murphy
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-08-23       Impact factor: 2.576

4.  Beta-lactam effects on mixed cultures of common respiratory isolates as an approach to treatment effects on nasopharyngeal bacterial population dynamics.

Authors:  David Sevillano; Lorenzo Aguilar; Luis Alou; María-José Giménez; Natalia González; Martha Torrico; Fabio Cafini; Pilar Coronel; José Prieto
Journal:  PLoS One       Date:  2008-12-04       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.